Manchester Capital Management’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-2,226
Closed -$179K 516
2016
Q4
$179K Hold
2,226
0.03% 193
2016
Q3
$178K Hold
2,226
0.03% 206
2016
Q2
$174K Hold
2,226
0.02% 210
2016
Q1
$122K Hold
2,226
0.02% 264
2015
Q4
$138K Hold
2,226
0.02% 258
2015
Q3
$140K Hold
2,226
0.02% 243
2015
Q2
$163K Hold
2,226
0.03% 232
2015
Q1
$145K Sell
2,226
-1,408
-39% -$93.6K 0.02% 234
2014
Q4
$236K Hold
3,634
0.03% 325
2014
Q3
$219K Hold
3,634
0.03% 329
2014
Q2
$252K Sell
3,634
-175
-5% -$11.3K 0.03% 308
2014
Q1
$249K Hold
3,809
0.04% 281
2013
Q4
$236K Hold
3,809
0.04% 296
2013
Q3
$204K Sell
3,809
-400
-10% -$20.6K 0.04% 320
2013
Q2
$192K Buy
+4,209
New +$182K 0.04% 314

Other funds holding STJ

Manchester Capital Management's STJ Position: Q1 2017 in Review

Manchester Capital Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 2,226 shares — an estimated $179K sold.

Manchester Capital Management first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $252K in Q2 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Manchester Capital Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Manchester Capital Management sold 2,226 St Jude Medical shares in Q1 2017, an estimated $179K.
  • Manchester Capital Management first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Manchester Capital Management's St Jude Medical position peaked at $252K in Q2 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Manchester Capital Management's 13F filing for Q1 2017, filed 25 Apr 2017.